JPH0881381A - Health and beauty-promoting agent having sod action, blood pressure-suppressing agent and constipation-improving agent - Google Patents

Health and beauty-promoting agent having sod action, blood pressure-suppressing agent and constipation-improving agent

Info

Publication number
JPH0881381A
JPH0881381A JP6242072A JP24207294A JPH0881381A JP H0881381 A JPH0881381 A JP H0881381A JP 6242072 A JP6242072 A JP 6242072A JP 24207294 A JP24207294 A JP 24207294A JP H0881381 A JPH0881381 A JP H0881381A
Authority
JP
Japan
Prior art keywords
green tea
tea extract
evaporation residue
health
water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP6242072A
Other languages
Japanese (ja)
Inventor
Akihiko Kimura
彰彦 木村
Naoto Ishikawa
直人 石川
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toyo Hakko Co Ltd
Original Assignee
Toyo Hakko Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyo Hakko Co Ltd filed Critical Toyo Hakko Co Ltd
Priority to JP6242072A priority Critical patent/JPH0881381A/en
Publication of JPH0881381A publication Critical patent/JPH0881381A/en
Pending legal-status Critical Current

Links

Landscapes

  • Beans For Foods Or Fodder (AREA)
  • Tea And Coffee (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

PURPOSE: To obtain a health and beauty-promoting agent having safety and excellent SOD actions (an action effectively removing O2 <-> thought as harmful for an organism and an action preventing disease, etc.) by using rice brans and soybeans as raw materials. CONSTITUTION: This health and beauty-promoting agent having the SOD action is characterized by blending 100 pts.wt. of distillation residue of a concentrated solution (e.g. a concentration of 40-50wt.%) of a fermented solution prepared by seeding Bacillus subtilis in a medium containing rice brans and soybeans, cultivating and filtering with 1-50 pts.wt. of extracted essence of green tea (e.g. a concentration of 40-50wt.%) as a value reduced to distillation residue. The fermented solution may contain flavonoid, and phytic acid or its salt may contain a green tea-extracted essence and the distillation residue (solid residue) may be used instead of the above solutions. This agent is also usable as a blood pressure-suppressing agent and a constipation-improving agent.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、SOD作用を有する健
康・美容増進剤、血圧抑制剤及び便秘改良剤に関する。
本発明は、活性酸素(O2 - )が原因となる各種の病
気、例えば、血流障害による病気(心筋梗塞、脳卒中、
高血圧、生理痛、肩こり、神経痛、腰痛、二日酔い
等)、成人病・内科疾患(癌、腎炎、肝炎、糖尿病
等)、美容・皮膚病(しみ、そばかす、肌荒れ、冷え
症、便秘、しわ、アトピー性皮膚炎等)等の治療、改良
等に広く利用される。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a health / beauty enhancer having SOD action, a blood pressure suppressor and a constipation improver.
The present invention relates to various diseases caused by active oxygen (O 2 ), for example, diseases caused by blood flow disorder (myocardial infarction, stroke,
High blood pressure, menstrual cramps, stiff shoulders, neuralgia, backache, hangover, etc., adult diseases / medical diseases (cancer, nephritis, hepatitis, diabetes, etc.), beauty / skin diseases (stains, freckles, rough skin, coldness, constipation, wrinkles, atopic nature) It is widely used for the treatment and improvement of dermatitis, etc.).

【0002】[0002]

【従来の技術】スーパーオキシドジスムターゼ(SOD
という。)は、酸素分子の1電子還元で生成するスーパ
ーオキシドラジカル(superoxide radi
cal,O2 - )の不均化反応(下式)を拡散律速に近
い速さで触媒し、細胞内のO2 - 濃度を低下させる酵素
である。 O2 - +O2 - +2H+ →H2 2 +O2 近年、O2 - が生体に有害ならば、その除去酵素である
このSODは、生体を活性酸素毒性から守るために存在
する筈のものであり、従って、この活性酸素を起因とし
て生じると考えられる病気等に有用であるとの観点か
ら、その反応機構、生理機構等が研究されている〔「活
性酸素−生物での生成・消去・作用の分子機構」(新装
版2刷、共立出版株式会社発行、中野稔ら編著)P.2
23〜230)〕。また、癌細胞ではSOD活性が低い
という事実があり、更に、SODと発癌との直接因果関
係は明らかではないが、SOD又はSOD様物質を癌細
胞に注入すると、増殖を抑えるという報告(記述)もあ
る(同、P.64)。
2. Description of the Related Art Superoxide dismutase (SOD
Say. ) Is a superoxide radical (superoxide radical) generated by one-electron reduction of an oxygen molecule.
cal, O 2 - disproportionation) (lower formula) catalyzed at a rate close to diffusion control, O 2 in the cell - an enzyme to reduce the concentration. O 2 + O 2 + 2H + → H 2 O 2 + O 2 If O 2 is harmful to the living body in recent years, this SOD, which is a scavenging enzyme, should exist to protect the living body from active oxygen toxicity. Therefore, the reaction mechanism, physiological mechanism, and the like are being studied from the viewpoint of being useful for diseases and the like that are considered to be caused by this active oxygen [[reactive oxygen-production / elimination in living organisms Molecular mechanism of action "(2 new editions, published by Kyoritsu Shuppan Co., Ltd., edited by Minoru Nakano) P. Two
23-230)]. In addition, there is a fact that SOD activity is low in cancer cells, and further, although a direct causal relationship between SOD and carcinogenesis is not clear, it is reported that injection of SOD or SOD-like substances into cancer cells suppresses proliferation (description). (P.64).

【0003】[0003]

【発明が解決しようとする課題】安全で且つSOD作用
(ここでいうSOD作用とは、活性酸素濃度を減少させ
る作用のみならず、これに起因して生じると考えられる
種々の病気の予防、改善の作用をも含む。)のある食品
があれば、人の健康及び美容にとって極めて有用なもの
となり、その必要性は極めて大きい。特に、近年のよう
にストレスが多く且つ多くの病気が発生している状況に
おいては、特に、その必要性が大きい。
[Problems to be Solved by the Invention] Safe and SOD action (The SOD action here means not only the action of decreasing the active oxygen concentration but also the prevention and improvement of various diseases which are considered to be caused by this. If there is a food having the effect of (1), it will be extremely useful for human health and beauty, and there is a great need for it. In particular, in a situation where stress is high and many diseases are occurring as in recent years, the necessity thereof is great.

【0004】本発明は、米糠類及び大豆類を原料として
用い、安全で且つ優れたSOD作用を有する健康・美容
増進剤、血圧抑制剤及び便秘改良剤、更には、フィチン
酸及びその塩の少なくとも一方と緑茶抽出エキスとを含
有させてなるSOD作用を有する健康・美容増進剤等を
提供することを目的とする。
The present invention uses rice bran and soybeans as raw materials, and is a health and beauty enhancer having a safe and excellent SOD action, an antihypertensive agent and a constipation improving agent, and at least phytic acid and its salts. An object of the present invention is to provide a health / beauty enhancer or the like having an SOD action, which comprises one side and a green tea extract.

【0005】[0005]

【課題を解決するための手段】以上の観点より、本発明
者等は、このSOD活性を有する健康・美容増進剤等と
して、安全な発酵物を利用したものはないか等につい
て、鋭意、種々検討した所、前記原料を用いて発酵させ
濾過して得た発酵液に所定の添加物を配合することによ
り、その目的を達成できることを発見して、本発明を完
成するに至ったものである。本第1発明のSOD作用を
有する健康・美容増進剤は、米糠類、大豆類及び水を含
む培地に枯草菌を接種し、培養させ、濾過して製造した
発酵液又は該発酵液の蒸発残分に、緑茶抽出エキス又は
該緑茶抽出エキスの蒸発残分を含有させてなることを特
徴とする。また、第6発明は、第1発明の健康・美容増
進剤を血圧抑制剤として利用したものであり、更に、第
11発明は同健康・美容増進剤を便秘改良剤に利用した
ものである。
From the above viewpoints, the inventors of the present invention diligently investigated whether or not there is a safe fermented substance used as a health / beauty enhancer having SOD activity. Upon investigation, it was discovered that by adding a predetermined additive to the fermentation liquor obtained by fermenting using the above-mentioned raw materials and filtering, it was possible to achieve the object, which led to the completion of the present invention. . The health / beauty enhancer having an SOD effect of the first invention is a fermentation liquor produced by inoculating Bacillus subtilis into a medium containing rice bran, soybeans and water, culturing and filtering, or an evaporation residue of the fermentation liquor. In addition, the green tea extract extract or the evaporation residue of the green tea extract extract is contained in each minute. A sixth invention uses the health / beauty enhancer of the first invention as a blood pressure suppressor, and the eleventh invention uses the health / beauty enhancer as a constipation improving agent.

【0006】この「緑茶抽出エキス」とは、茶葉からメ
タノール、エタノール、酢酸エチル等(特にメタノー
ル、エタノール)を溶媒として抽出したものであり、抽
出成分の濃度は、5〜50重量%程度とすることができ
る。そして、この緑茶抽出エキスの配合割合は、第2発
明に示すように、その蒸発残分換算にて、上記発酵液の
蒸発残分100重量部に対して1〜50重量部とするこ
とができる。これが、1重量部未満では、その効果が十
分に期待できないし、50重量部を越えると、味覚的に
飲用することが困難となるためである。また、第3、第
8及び第13発明において、この緑茶抽出エキスは、メ
タノール、エタノール、又はメタノール/エタノール混
合液にて抽出して水溶性のものとしたものである。
The "green tea extract" is obtained by extracting tea leaves using methanol, ethanol, ethyl acetate and the like (particularly methanol and ethanol) as a solvent, and the concentration of the extracted components is about 5 to 50% by weight. be able to. And, as shown in the second invention, the mixing ratio of the green tea extract can be 1 to 50 parts by weight in terms of the evaporation residue, based on 100 parts by weight of the evaporation residue of the fermentation liquid. . This is because if it is less than 1 part by weight, the effect cannot be expected sufficiently, and if it exceeds 50 parts by weight, it becomes difficult to taste and drink. In addition, in the third, eighth, and thirteenth inventions, the green tea extract is extracted with methanol, ethanol, or a mixed solution of methanol / ethanol to be water-soluble.

【0007】本第4発明のSOD作用を有する健康・美
容増進剤は、米糠類、大豆類及び水を含む培地に枯草菌
を接種し、培養させ、濾過して製造した発酵液又は該発
酵液の蒸発残分に、フラボノイドを含有させてなること
を特徴とする。また、第9発明は、第4発明の健康・美
容増進剤を血圧抑制剤として利用したものであり、更
に、第14発明は同健康・美容増進剤を便秘改良剤に利
用したものである。この「フラボノイド」は、広く植物
界に分布しており、二つのフェニル基がピラン環あるい
はそれに近い構造の3個の炭素原子をはさんで結合して
いる、いわゆるC6 −C3 −C6 炭素骨格から成る化合
物群である。このフラボノイドは、緑茶抽出エキス中の
蒸発残分に対して、13〜14重量%含まれている。そ
して、このフラボノイドの配合割合は、発酵液100重
量部(例えばエキス濃度が40〜50重量%の場合)に
対して0.1〜7重量部程度とすることができる。これ
が、0.1重量部未満では、その効果が十分に期待でき
ないし、7重量部を越えると味覚的に飲用することが困
難となるためである。
The health / beauty enhancer having an SOD action of the fourth aspect of the present invention is a fermentation liquor produced by inoculating Bacillus subtilis in a medium containing rice bran, soybeans and water, culturing and filtering, or the fermentation broth. It is characterized in that flavonoids are contained in the evaporation residue of. A ninth aspect of the invention uses the health / beauty enhancer of the fourth invention as a blood pressure suppressor, and a fourteenth aspect of the invention uses the health / beauty enhancer as a constipation-improving agent. The "flavonoid" is widely distributed in the plant kingdom, the two phenyl groups are bonded across the three carbon atoms of the pyran ring, or close to it the structure, so-called C 6 -C 3 -C 6 It is a group of compounds consisting of carbon skeleton. This flavonoid is contained in 13 to 14% by weight based on the evaporation residue in the green tea extract. The blending ratio of the flavonoid can be about 0.1 to 7 parts by weight with respect to 100 parts by weight of the fermentation broth (for example, when the extract concentration is 40 to 50% by weight). This is because if the amount is less than 0.1 part by weight, the effect cannot be expected sufficiently, and if it exceeds 7 parts by weight, it becomes difficult to taste and drink.

【0008】上記「米糠類」とは、米胚芽、脱脂米胚
芽、米糠、脱脂米糠等をいい、「大豆類」とは、脱脂大
豆、キナ粉、大豆粉、大豆カス、これらの加水分解物等
をいう。通常、これらの添加割合は、米糠類を100重
量部とする場合、大豆類が10〜20重量部である。こ
の発酵条件は、通常、pHが7.5〜10(特に9前
後)、培養温度が40〜45℃程度である。尚、培地原
料としてはプロテアーゼを用いることができる。この場
合は、大豆ペプチドを更に分解するので、有用である。
The above-mentioned "rice bran" means rice germ, defatted rice germ, rice bran, defatted rice bran and the like, and "soybeans" means defatted soybean, quina flour, soybean flour, soybean dregs and hydrolysates thereof. Etc. Usually, these are added in an amount of 10 to 20 parts by weight of soybeans when the rice bran is 100 parts by weight. The fermentation conditions are usually pH of 7.5 to 10 (especially around 9) and culture temperature of about 40 to 45 ° C. In addition, protease can be used as a medium material. This case is useful because it further decomposes the soybean peptide.

【0009】上記「発酵液」としては、培養させた培養
発酵液を濾過したままの液でもよいし、これを脱色等の
後処理をした液でもよいし、これを濃縮した濃縮液でも
よい。尚、上記のように、この発酵液の蒸発残分(固形
分)を用いてもよい。本第5発明のSOD作用を有する
健康・美容増進剤は、フィチン酸及びその塩の少なくと
も一方と、緑茶抽出エキス(又は該緑茶抽出エキスの蒸
発残分)とを含有させてなることを特徴とする。また、
第10発明は、第5発明の健康・美容増進剤を血圧抑制
剤として利用したものであり、更に、第15発明は同健
康・美容増進剤を便秘改良剤に利用したものである。
The "fermentation solution" may be a solution obtained by culturing the cultured culture fermentation solution as it is, a solution that has been subjected to post-treatment such as decolorization, or a concentrated solution obtained by concentrating the solution. As described above, the evaporation residue (solid content) of this fermentation liquid may be used. The health / beauty enhancer having an SOD action of the fifth aspect of the present invention is characterized by containing at least one of phytic acid and a salt thereof and a green tea extract (or an evaporation residue of the green tea extract). To do. Also,
A tenth invention uses the health / beauty enhancer of the fifth invention as a blood pressure inhibitor, and a fifteenth invention uses the health / beauty enhancer as a constipation improving agent.

【0010】上記「フィチン酸」としては、合成フィチ
ン酸でも、抽出単離したフィチン酸でもよい。また、
「その塩」としては、非毒性塩が用いられ、金属、有機
塩基、塩基性アミノ酸、有機エステル残基等との塩が用
いられ、例えば、カリウム、ナトリウム、アルギニン、
オルニチン、リジン、ヒスチジン、グルカミン、モノエ
タノールアミン等の塩とすることができる。このフィチ
ン酸が酸性を示すことから、通常、pHが6〜8程度の
その塩を用いる。この塩の水溶性の有無は問わないが、
健康・美容増進剤等を水溶液として用いることが多いの
で、水溶性のものが好ましい。また、このフィチン酸及
びその塩類は、上記発酵液に多く含まれており、リン濃
度より換算すると、この蒸発残分100重量部に対し
て、フィチン酸相当物が6〜7重量部含まれている。従
って、本第5、第10及び第15発明のように、フィチ
ン酸等に所定量の緑茶抽出エキスを含有しても、上記第
1発明の場合と同様に、同等の効果が確実に得られるも
のと考えられる。
The above-mentioned "phytic acid" may be synthetic phytic acid or phytic acid extracted and isolated. Also,
As the “salt”, a non-toxic salt is used, and a salt with a metal, an organic base, a basic amino acid, an organic ester residue, etc. is used, and examples thereof include potassium, sodium, arginine,
It may be a salt of ornithine, lysine, histidine, glucamine, monoethanolamine or the like. Since this phytic acid exhibits acidity, a salt thereof having a pH of about 6 to 8 is usually used. It does not matter whether this salt is water-soluble or not,
Since a health / beauty enhancer or the like is often used as an aqueous solution, a water-soluble one is preferable. Further, this phytic acid and its salts are contained in a large amount in the fermentation broth, and when converted from the phosphorus concentration, 6 to 7 parts by weight of the phytic acid equivalent is contained with respect to 100 parts by weight of the evaporation residue. There is. Therefore, as in the fifth, tenth, and fifteenth inventions, even if a predetermined amount of green tea extract is contained in phytic acid or the like, as in the case of the first invention, the same effect is surely obtained. It is considered to be a thing.

【0011】[0011]

【実施例】以下実施例により本発明を具体的に説明す
る。 (1)発酵液の製造及び健康食品(健康・美容増進剤等
をいう。)の試験品の調製 まず、以下に示す方法により発酵液を製造する。即ち、
脱脂米糠;30kg、大豆かす(又は脱脂大豆);3k
g、苦汁;5kg、水;500kgを使用した。尚、p
Hは9前後である。上記培地を121℃、30分にて殺
菌し、その後冷却し、次いで、納豆菌(製造元;成瀬醗
酵化学研究所)0.05Kgを接種し、40〜45℃に
て約48時間、通気、撹拌して培養させた。
The present invention will be described in detail with reference to the following examples. (1) Production of Fermentation Liquid and Preparation of Test Product of Health Food (Health / Beauty Promoter etc.) First, a fermentation liquid is produced by the following method. That is,
Defatted rice bran; 30 kg, soybean meal (or defatted soybean); 3 k
g, bittern, 5 kg, water; 500 kg were used. In addition, p
H is around 9. The above medium was sterilized at 121 ° C. for 30 minutes, then cooled, and then inoculated with 0.05 Kg of natto bacterium (manufacturer; Naruse Fermentation and Chemical Research Institute), aeration and stirring at 40 to 45 ° C. for about 48 hours. And cultured.

【0012】その後、この培養物を圧搾濾過し、活性炭
及びパーライトで処理をして脱臭、脱色をし、ほぼ透明
の発酵液(発酵エキス)を得た。尚、この活性炭として
は、粉末活性炭(活性炭S、活性炭K等)、粒状活性炭
(活性炭SG等)の種々のものを使用でき、パーライト
としては、「パーライトNo.4180」(ダイカライ
ンオリエント(株)製)を使用した。この発酵液は、無
色若しくは淡黄色の透明液体であり、発酵の香味があ
り、水分92〜94%(常圧加熱乾燥法による。)、リ
ン約300〜400mg/100g(バナドモリブデン
分析方法による。)で、一般生菌、大腸菌、カビ、酵母
並びに砒素、鉛、カドミウム、スズは検出されなかっ
た。
Thereafter, this culture was squeezed and filtered, treated with activated carbon and perlite to deodorize and decolorize, and an almost transparent fermentation liquor (fermented extract) was obtained. As the activated carbon, various types such as powdered activated carbon (activated carbon S, activated carbon K, etc.) and granular activated carbon (activated carbon SG, etc.) can be used, and as the perlite, “Perlite No. 4180” (Daikaline Orient Co., Ltd.) Manufactured) was used. This fermented liquid is a colorless or pale yellow transparent liquid, has a flavor of fermentation, water content of 92 to 94% (according to normal pressure heating and drying method), and phosphorus of about 300 to 400 mg / 100 g (according to vanad molybdenum analysis method). In general, live bacteria, Escherichia coli, mold, yeast, arsenic, lead, cadmium and tin were not detected.

【0013】本健康食品の試験品1としては、上記発酵
液100重量部に対して、3重量部の緑茶抽出エキス
(メタノール又はエタノール抽出液、固形分濃度;47
〜48重量%、比重;1.07〜1.09)を配合した
もの(蒸発残分比が発酵液分/抽出エキス分=100:
20)を用いた。尚、この固形分濃度はBrix値とし
て求め、エタノール及びグリセリン(主としてエタノー
ル)濃度が約50重量%、水濃度が約2.6重量%であ
る。また、この緑茶抽出エキスには、相当量のフラボノ
イドが含まれていると考えられる。
As the test product 1 of this health food, 3 parts by weight of the green tea extract (methanol or ethanol extract, solid content concentration; 47: 100 parts by weight of the fermentation liquid) was used.
˜48% by weight, specific gravity; 1.07 to 1.09) (evaporation residue ratio: fermentation liquor content / extracted extract content = 100:
20) was used. The solid content concentration was determined as a Brix value, and the concentration of ethanol and glycerin (mainly ethanol) was about 50% by weight, and the concentration of water was about 2.6% by weight. Moreover, it is considered that this green tea extract contains a considerable amount of flavonoids.

【0014】(2)性能評価 (A)SOD作用について 以下の条件下において、H2 2 に関する試験(表1、
表2)、OHに関する試験(表3)、O2 −キサンチン
系における試験(表4)を行い、その結果を各表に示し
た。テスト品としては、上記試験品1としては水による
5倍希釈液を使用した。
(2) Performance Evaluation (A) SOD Action Under the following conditions, a test on H 2 O 2 (Table 1,
Table 2), a test for OH (Table 3), and a test in the O 2 -xanthine system (Table 4) were performed, and the results are shown in each table. As a test product, a 5-fold diluted solution with water was used as the test product 1.

【0015】[0015]

【表1】[Table 1]

【0016】 表 1 −−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−− 〔例1〕 H2 2 −−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−− 0分 10分 平均/分 PLCO モル/分 −−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−− control品 5 50 2.5 348 −−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−− 試験品1 75 73 0.2 28 −−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−Table 1 --------------------------------------------- [Example 1] H 2 O 2 --- −−−−−−−−−−−−−−−−−−−−−−−−−−−−−−− 0 min 10 min Average / min PLCO mol / min −−−−−−−−− −−−−−−−−−−−−−−−−−−−−−−−−−− control product 5 50 2.5 348 −−−−−−−−−−−−−−−−− −−−−−−−−−−−−−−−−− Test product 1 75 73 0.2 28 −−−−−−−−−−−−−−−−−−−−−−−− −−−−−−−−−−−

【0017】[0017]

【表2】[Table 2]

【0018】 表 2 −−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−− 〔例2〕 H2 2 −−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−− 0分 10分 平均/分 PLCO モル/分 −−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−− control品 75 23 5.2 723 −−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−− 試験品1 75 70 0.5 70 −−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−Table 2 --- ------------------------------------- [Example 2] H 2 O 2 --- −−−−−−−−−−−−−−−−−−−−−−−−−−−−−−− 0 min 10 min Average / min PLCO mol / min −−−−−−−−− −−−−−−−−−−−−−−−−−−−−−−−−−− control product 75 23 5.2 723 −−−−−−−−−−−−−−−− −−−−−−−−−−−−−−−−−− Test product 1 75 70 0.5 70 −−−−−−−−−−−−−−−−−−−−−−−− −−−−−−−−−−−

【0019】[0019]

【表3】[Table 3]

【0020】 表 3 −−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−− OH 試料 −−−−−−−−−−−−−−−−−−−−− 〔例1〕 〔例2〕 −−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−− STIMULATER/INCUBATION 40分 40分 −−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−− control品 174.8 12.49 −−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−− 試験品1 153.0 1.87 −−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−Table 3 −−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−− OH sample −−−−−−−−−−−− ---------------- [Example 1] [Example 2] --------------------------------------- --- STIMULATER / INCUBATION 40 minutes 40 minutes ----------------------------------- −−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−− Test product 1 153.0 1.87 −−−−−−−−− −−−−−−−−−−−−−−−−−−−−−−−−−

【0021】[0021]

【表4】[Table 4]

【0022】 表 4 −−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−− O2 −キサンチン系 −−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−− 試料 O.D.(nM) nM/分 −−−−−−−−−−−−−−−−−−−−−−−− C(2分−1分) C−Black −−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−− control品 0.0251 1.190 −−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−− 試験品1 0.0244 0.0205 0.972 −−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−Table 4 −−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−− O 2 -xanthine system ---------- −−−−−−−−−−−−−−−−−−−−−−−−−− Sample O. D. (NM) nM / min −−−−−−−−−−−−−−−−−−−−−−−− C (2 min-1 min) C-Black −−−−−−−−−− −−−−−−−−−−−−−−−−−−−−−−−− control product 0.0251 1.190 −−−−−−−−−−−−−−−−−−− --------------------- Test product 1 0.0244 0.0205 0.972 ------------------------------ −−−−−−−−−−

【0023】以上の表1〜4に示すように、本試験品1
においては、コントロール品と比べてSOD作用に優れ
ることを示している。尚、以上よりSOD活性は、46
0ユニット/ml(1カップ10ml)といえる。更
に、発酵液及び緑茶抽出エキスの相乗効果について以下
のような試験をした。即ち、下記の配合割合からなる各
試料(No.A〜C)を調製した。 −−−−−−−−−−−−−−−−−−−−−−−−−−−− No.A 発酵液 100g −−−−−−−−−−−−−−−−−−−−−−−−−−−− No.B 緑茶抽出エキス 1g 精製水 99g −−−−−−−−−−−−−−−−−−−−−−−−−−−− No.C 発酵液 99g 緑茶抽出エキス 1g −−−−−−−−−−−−−−−−−−−−−−−−−−−− 上記各試料を、以下に示す測定方法によりSOD活性を
測定した 〔SOD活性の測定方法〕本方法はEPR(電子スピン
共鳴)装置を用いる方法であり、最近、(財)日本食品
分析センターにて試験項目;「スーパーオキシド消去活
性」として行われるようになった方法である。即ち、ま
ず、上記各均一化試料1gに0.1Mリン酸緩衝液(p
H7.8)を加え、充分に抽出を行い抽出液を得る。そ
の後、以下に示す試薬を混合する。 2mMヒポキサンチン/リン酸緩衝液 50μl 5.5mM DETAPAC(diethlenetriaminepentaacetic a
cid)/リン酸緩衝液35μl 抽出液或いは標準SOD(スーパーオキシドジスムター
ゼ)50μl DMPO(5,5-dimethyl-1-pyrroline-1-oxide)15μl 0.4units/mlキサンチンオキシターゼ/リン酸緩衝液
50μl 次いで、この混合液を、特殊偏平セル(日本電子株式会
社製、容量;約130μl)に吸い取り、ESR装置
(日本電子株式会社製、JES-FR80型)にセットし、40
秒後に掃引を開始して、以下に示すESR操作条件にて
測定を行った。尚、このSOD活性測定は、試料調整後
1日後の溶液を測定したものである。 〔ESR操作条件〕 温度 室温 マイクロ波出力 8mW 磁場 334.7mT±5mT 変調 100kHz,0.79×0.
1mT 増幅率 3.2×100 応答時間 0.1秒 掃引時間 2分 そして、Mn2+のピーク高と測定シグナルのピーク高の
比を求める。次いで、標準SOD(0〜15units/ml)
で検量線を作成し、抽出液で得た値を内挿し試料中の消
去活性を算出した。この結果は以下の通りである。単位
はUNIT/gである。「活性相加理論値」は、試料No.A
及びBの各SOD活性値を用いて単に積算したものであ
る。 −−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−− No.A 3.965×103 −−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−− No.B 0.660×103 −−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−− No.C 5.300×103 (活性相加理論値4.590×103 ) −−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−− 発酵液及び緑茶抽出エキスを含むNo.Cでは、実際の
SOD活性値が活性相加理論値の1.15倍を示し、相
乗効果をあることを示している。
As shown in Tables 1 to 4 above, this test product 1
Indicates that the SOD action is superior to that of the control product. From the above, the SOD activity was 46
It can be said that it is 0 unit / ml (1 cup 10 ml). Furthermore, the following tests were conducted for the synergistic effect of the fermented liquid and the green tea extract. That is, each sample (No. A to C) having the following blending ratio was prepared. --------------------------------------- No. A Fermentation liquid 100 g ----------------------------- No. B green tea extract 1 g Purified water 99 g -------------------- No. C Fermented liquid 99 g Green tea extract 1 g ------------------------------- SOD activity was measured by the following measurement method for each of the above samples. Measured [Method of measuring SOD activity] This method is a method using an EPR (electron spin resonance) device, and is recently performed as a test item; "superoxide scavenging activity" at the Japan Food Research Center. That's how it became. That is, first, to 1 g of each homogenized sample, 0.1 M phosphate buffer solution (p
H7.8) is added and extraction is sufficiently performed to obtain an extract. Then, the following reagents are mixed. 2 mM hypoxanthine / phosphate buffer 50 μl 5.5 mM DETAPAC (diethlenetriaminepentaacetic a
cid) / phosphate buffer 35 μl extract or standard SOD (superoxide dismutase) 50 μl DMPO (5,5-dimethyl-1-pyrroline-1-oxide) 15 μl 0.4 units / ml xanthine oxidase / phosphate buffer 50 μl , This mixed solution was sucked into a special flat cell (made by JEOL Ltd., capacity: about 130 μl) and set in an ESR device (JES-FR80 type made by JEOL Ltd.), 40
The sweep was started after 2 seconds, and the measurement was performed under the ESR operation conditions shown below. In addition, this SOD activity measurement is a measurement of the solution one day after the sample preparation. [ESR operation conditions] temperature room temperature microwave output 8 mW magnetic field 334.7 mT ± 5 mT modulation 100 kHz, 0.79 × 0.
1 mT Amplification factor 3.2 × 100 Response time 0.1 seconds Sweep time 2 minutes Then, the ratio between the peak height of Mn 2+ and the peak height of the measurement signal is obtained. Next, standard SOD (0 to 15 units / ml)
A calibration curve was prepared in step 1 and the values obtained with the extract were interpolated to calculate the erasing activity in the sample. The results are as follows. The unit is UNIT / g. “Activity additive theoretical value” is the sample No. A
And SOD activity values of B are simply integrated. -------------------------------------------- A 3.965 × 10 3 −−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−− No. B 0.660 × 10 3 −−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−− No. C 5.300 * 10 < 3 > (Activity addition theoretical value 4.590 * 10 < 3 >) -----------------------. ----- No. containing the fermented liquid and the green tea extract. In C, the actual SOD activity value is 1.15 times the active additive theoretical value, which indicates that there is a synergistic effect.

【0024】(B)ラットの血圧上昇期における血圧の
変動について 以下の条件下において、上記発酵液100重量部に対し
て、上記緑茶抽出エキス1.5重量部を配合したものを
試験品2とし、この試験品2の投与による血圧の変動を
評価した。その結果を図1に示す。
(B) Fluctuations in blood pressure during elevated blood pressure in rats Under the following conditions, 100 parts by weight of the fermentation broth was mixed with 1.5 parts by weight of the green tea extract to give a test product 2. The change in blood pressure due to the administration of this test product 2 was evaluated. The result is shown in FIG.

【0025】〔試験条件〕 動物:ラット;対照用・雄3匹、試験品用・雄4匹、
計7匹。そして、このラットの齢は6週齢で、その血圧
は150mmHg以上である。尚、このラットは3週齢
より血圧が上がる遺伝的性質を持つラット(以下、SH
Rという。)である。 試験投与法:給水ビンにより自由摂取。 室内:温度 23±1℃、湿度 50%±10%。 飲料:上記試験品2(SOD対応)の10%溶液にグ
ルコース及びクエン酸を入れ飲みやすくした。 血圧測定;1回/2週。 使用飼料;いずれも共通の飼料(オリエンタル酵母社
製「MF」)を用いた。この結果によれば、対照群と比
べて、本試験品2を用いる場合は、血圧上昇を抑制する
効果があることを示している。
[Test conditions] Animal: rat; 3 males for control, 4 males for test product,
7 in total. The age of this rat is 6 weeks, and its blood pressure is 150 mmHg or higher. It should be noted that this rat has a genetic property that blood pressure increases from 3 weeks of age (hereinafter referred to as SH
Called R. ). Test administration method: Free intake by water bottle. Indoor: Temperature 23 ± 1 ° C, humidity 50% ± 10%. Beverage: Glucose and citric acid were added to a 10% solution of the test product 2 (corresponding to SOD) to make it easy to drink. Blood pressure measurement; once every 2 weeks. Feed used: Common feed (“MF” manufactured by Oriental Yeast Co., Ltd.) was used in all cases. The results show that the use of this test product 2 has an effect of suppressing an increase in blood pressure as compared with the control group.

【0026】(C)ラットの高血圧完成期における血圧
の変動について 以下の条件以外は上記と同じ条件により、試験品2の投
与による血圧の変動を評価した。その結果を図2に示
す。 〔試験条件〕 動物:ラット(上記SHR);対照用・雄4匹、試験
品用・雄4匹、計8匹。そして、このラットの齢は12
〜15週齢で、その血圧は180mmHg以上である。
これ以外の条件は、上記と同じである。この結果によれ
ば、図2に示すように、高血圧を抑制する効果あると同
時に投与時間の経過に伴って抑制効果に優れることを示
している。
(C) Fluctuation of blood pressure in the hypertensive completion stage of rats The fluctuation of blood pressure due to administration of Test Product 2 was evaluated under the same conditions as above except the following conditions. The result is shown in FIG. [Test Conditions] Animal: rat (above SHR); control: 4 males, test product: 4 males, 8 in total. And the age of this rat is 12
At 15 weeks of age, its blood pressure is 180 mmHg or higher.
The other conditions are the same as above. According to this result, as shown in FIG. 2, it has an effect of suppressing hypertension and, at the same time, an excellent suppressing effect with the passage of administration time.

【0027】(D)モニター試験 (1)便秘改良効果について、以下の如くモニター試験
をした所、以下のような良好な結果を得た。この試験方
法は、便秘症の女性50名(有効回答数は49名)を
対象、起床時30分以内に原液(発酵液)を5ml摂
取、である。その結果、第1日目には38名の女性に便
通があり、第2日目及び第3日目には49名全員に便通
があった。
(D) Monitor test (1) Regarding the constipation-improving effect, a monitor test was conducted as follows, and the following good results were obtained. This test method is intended for 50 women with constipation (the number of valid answers is 49), and 5 ml of the stock solution (fermented solution) is ingested within 30 minutes of waking up. As a result, 38 women had bowel movements on the first day and all 49 women had bowel movements on the second and third days.

【0028】(2)更に、上記発酵液60重量部、上記
緑茶抽出エキス1.2重量部及びオリゴ糖14重量部、
主に他は精製水からなる試験品(10ml入りポーショ
ン)を人に使用するというモニター試験をした所、以下
のような良好な結果を得た。 A(58才、女性) 〔モニター開始前の症状〕顔が黒ずんでいて、階段の昇
り降りが大変つらく、血圧も165と高く降下剤を常飲
していた。 〔毎日2個飲料後の結果〕1週間ほどで足が軽くなっ
た。降下剤は止め、3週間ほどで血圧が130になっ
た。2ヵ月で、顔が見違えるほど白くなる。10才は若
く見えるようになった。
(2) Further, 60 parts by weight of the fermentation broth, 1.2 parts by weight of the green tea extract and 14 parts by weight of oligosaccharide,
The following good results were obtained when a monitor test was conducted in which a test product (portion containing 10 ml) mainly composed of purified water was used for humans. A (58 years old, female) [Symptoms before the start of the monitor] His face was dark, the climbing of stairs was very difficult, his blood pressure was 165, and he was constantly taking a depressant. [Results after 2 drinks daily] My legs became lighter in about 1 week. The antihypertensive drug was stopped and the blood pressure became 130 in about 3 weeks. After two months, my face turns white so much that I can't see it. The 10-year-old started to look younger.

【0029】B(70才、男性) 〔モニター開始前の症状〕日常でも心肺機能が弱いため
階段を昇ると息が切れて、足も引きずるようだった。 〔毎日3個(朝・昼・晩)飲料後の結果〕2週間ほど
で、体が軽く感じられ始める。1ヵ月ほどで、階段を昇
っても息が切れなくなる。4ヵ月後に病院で心肺機能を
見てもらったところかなりよくなっている。この冬は始
めて、風邪をひかずに入院の必要はなく元気であった。
B (70 years old, male) [Symptoms before the start of the monitor] Even in everyday life, my cardiopulmonary function was weak, so I felt like I was out of breath when I climbed the stairs and dragged my legs. [Results after 3 daily drinks (morning, noon, evening)] In about 2 weeks, the body begins to feel light. After about a month, I can't breathe out even when I climb the stairs. Four months later, when I was asked to see cardiopulmonary function at the hospital, it was much better. For the first time this winter, I was fine without having to be hospitalized without catching a cold.

【0030】C(52才、女性) 〔モニター開始前の症状〕高血圧で糖尿病や便秘に悩ま
されていた。血圧は上が180で下が95である。 〔毎日2個(2ヵ月間)その後毎日1個飲料後の結果〕
4日目より尿が今までの2倍ほど出るようになり体の調
子も良くなる。宿便も3日に一度出るようになる。その
後2日に一度になる。2ヵ月後に医師から血圧降下剤を
飲まなくても良いと言われる。血圧は、上が145、下
が78になり、薬を必要としなくなった。
C (52 years old, female) [Symptoms before starting monitoring] He was suffering from diabetes and constipation due to high blood pressure. The blood pressure is 180 at the top and 95 at the bottom. [Results after 2 daily drinks (for 2 months) then 1 daily drink]
From the 4th day, urine is about twice as much as before and my body is feeling better. The stools will also appear once every three days. Then every two days. Two months later, my doctor tells me that I don't have to take blood pressure lowering drugs. His blood pressure was 145 on the upper side and 78 on the lower side, and he no longer needed medicine.

【0031】D(23才、女性) 〔モニター開始前の症状〕幼少の頃より便秘がひどく1
0日から2週間に1回の通便であった。顔にも細かい吹
出物が常にあり、皮膚もカサカサとした状態であった。
どちらかと言うと細身であるが下腹部が幼児体形のよう
に突き出ていて、かなり悩んでいた。 〔最初の2日5個その後毎日2個飲料後の結果〕翌日の
朝、通便があった。それより毎日通便がある。1ヵ月半
後には、顔のブツブツが全くなくなり、肌がつややかに
なった。化粧のりがとても良くなった。 E(70才、女性) 〔モニター開始前の症状〕血圧200の高血圧のため入
院していた。 〔毎日2個(朝・晩)飲料後の結果〕10日ほどで血圧
が下がり、退院することができた。現在140である。
D (23 years old, female) [Symptoms before the start of monitoring] Constipation was severe 1 since childhood.
She had a flight once every two weeks from the 0th day. There were always small pimples on the face, and the skin was dry.
It was rather slender, but the lower abdomen was protruding like an infant figure, and I was considerably worried. [Results after 5 drinks for the first 2 days and 2 drinks every day] The following morning, there was a bowel movement. There are daily flights than that. After a month and a half, my face was completely smooth and my skin was shiny. The makeup glue has improved very much. E (70 years old, female) [Symptoms before starting monitoring] He was hospitalized for high blood pressure of 200. [Results after 2 daily drinks (morning and evening)] Blood pressure dropped in about 10 days and I was able to be discharged from the hospital. Currently 140.

【0032】F(68才、女性) 〔モニター開始前の症状〕疲れが残り体がだるく、体も
固くなっていた。 〔毎日2個(朝・夕)飲料後の結果〕2日目より肌がし
っとりして化粧のりが良くなった。2週間目より疲れも
抜けて、体が軽く思うように動くようになった。 G(45才、男性) 〔モニター開始前の症状〕糖尿病で度々2〜3週間の入
院を繰り返していて、その治療中に肝臓を痛めた。 〔毎日2個飲料後の結果〕2ヵ月後肝臓は、完全に良く
なったと医師に言われ4ヵ月後糖尿病も良くなり、仕事
ができるまでになり社会復帰ができた。入院の必要はな
くなった。
F (68 years old, female) [Symptoms before starting monitoring] I was tired and tired, and my body was also stiff. [Results after 2 daily drinks (morning and evening)] Moisturized skin and improved makeup paste from the 2nd day. I was less tired than in the second week and I started to move as I wanted. G (45 years old, male) [Symptoms before starting monitoring] Diabetes was frequently hospitalized for 2 to 3 weeks, and the liver was hurt during the treatment. [Results after 2 daily drinks] After 2 months, my doctor told me that my liver had completely improved, and after 4 months I had better diabetes, and I was able to get back to work by returning to work. There is no need for hospitalization.

【0033】(E)実施例の効果のまとめ 上記のように、本発酵液は有害な菌及び重金属は認めら
れず、且つ完全な天然原料による自然発酵物のため、安
全である。そして、上記結果に示すように、SOD作用
に優れるので、上記のように血圧抑制効果に優れる結果
を示している。尚、このSOD作用に優れることから、
血圧抑制効果以外にも、このSOD作用に起因する効果
は、同様に期待されるものといえる。更に、この発酵液
は、上記緑茶抽出エキスを体内に有効に取り込む作用が
あるものと、本発明者等は考えている。この点は、今後
の詳細な研究を待つ必要があるが、いずれにしても、本
発酵液と緑茶抽出エキスを併用すれば、SOD作用に優
れるとともに、安心して人が飲用でき、更に人体にとっ
て大変有用であることは、明らかである。また、発酵液
及び緑茶抽出エキスともに水溶性のため、前述の試験に
示すように水に溶解させて水溶液飲料、食品等として使
用することができ、そのため体内での吸収に優れるとい
える。更に(D)のモニター試験に示すように、ポーシ
ョン(フレッシュミルクを入れている小さな容器形状を
いう。)型容器にこの試験品(水溶液)を入れた飲料
(食品)として試験しているように、種々の水溶液商品
(飲料、ドリンク剤等)とすることも容易である。
(E) Summary of Effects of Examples As described above, the present fermentation liquor is safe because harmful bacteria and heavy metals are not recognized, and it is a natural fermented product of completely natural raw materials. As shown in the above results, the SOD action is excellent, and thus the blood pressure suppressing effect is excellent as described above. In addition, since it is excellent in this SOD action,
In addition to the blood pressure suppressing effect, it can be said that the effects resulting from this SOD action are expected in the same manner. Furthermore, the present inventors believe that this fermented liquid has an action of effectively incorporating the green tea extract into the body. In this regard, it is necessary to wait for further detailed research, but in any case, if this fermentation broth and green tea extract are used in combination, the SOD action is excellent and it can be safely consumed by humans, and it is difficult for the human body. Clearly useful. Further, since both the fermented liquor and the green tea extract are water-soluble, they can be dissolved in water as shown in the above-mentioned test to be used as an aqueous solution drink, food, etc. Therefore, it can be said that they are well absorbed in the body. Furthermore, as shown in the monitor test of (D), it is tested as a beverage (food) in which this test product (aqueous solution) is put in a potion (a small container shape containing fresh milk) type container. It is also easy to make various aqueous products (beverages, drinks, etc.).

【0034】尚、本発明においては、上記具体的実施例
に示すものに限られず、目的、用途に応じて本発明の範
囲内で種々変更した実施例とすることができる。即ち、
上記発酵液等と緑茶抽出エキス等とからなる健康増進剤
等の形態は、通常、上記実施例に示すように水溶液若し
くは原液等の液状であるが、これに限らず、この液状健
康増進剤を吸液性粉末等に含浸させた粉末品、造粒させ
た造粒品、他の粉末成分(増量剤等)に配合してなる錠
剤、又はマイクロカプセル、ソフトカプセル、ハードカ
プセル、あめ、ゼリー、及びビスケット等に充填若しく
は配合させたもの等とすることができる。また、これら
の水溶液、粉末品等を所定容器に充填してなる商品形
態、またこれ単独で使用するか他剤(水溶液のもの、油
性液のもの若しくは粉末を問わない。)に配合して使用
するかについても特に限定されず、例えば、上記実施例
にて言及しているようなポーション型でもよいし、他形
状容器に充填してもよいし、粉末品をスティック状容器
(袋)に充填したものでもよいし、更に、従来の清涼飲
料水、ドリンク剤、乳製品、油剤化製品等に配合、分散
して使用してもよい。尚、この分散は油中水型、水中油
型を問わない。
The present invention is not limited to the specific examples described above, and various modifications may be made within the scope of the present invention depending on the purpose and application. That is,
The form of the health enhancer or the like consisting of the fermented liquor or the like and the green tea extract or the like is usually a liquid such as an aqueous solution or an undiluted solution as shown in the above Examples, but not limited to this, the liquid health enhancer Powder products impregnated with liquid-absorbent powder, granulated granulated products, tablets blended with other powder components (filler, etc.), or microcapsules, soft capsules, hard capsules, candy, jelly, and biscuits. Etc. can be filled or mixed. In addition, a product form in which a predetermined container is filled with these aqueous solution or powder product, or used alone or in combination with other agent (whether aqueous solution, oily liquid or powder) Whether or not it is not particularly limited, for example, it may be a potion type as mentioned in the above-mentioned examples, may be filled in a container having another shape, or a powder product may be filled in a stick-shaped container (bag). These may be used, or may be further mixed with and dispersed in conventional soft drinks, drinks, dairy products, oil-based products and the like. The dispersion may be water-in-oil type or oil-in-water type.

【0035】[0035]

【発明の効果】本健康・美容増進剤は、SOD作用に優
れるので、SOD作用に起因する効果(例えば、血圧抑
制効果等)に優れる。従って、本健康・美容増進剤の使
用により、活性酸素が原因となる各種の病気、例えば、
血流障害による病気(心筋梗塞、脳卒中、高血圧、生理
痛、肩こり、神経痛、腰痛、二日酔い等)、成人病・内
科疾患(癌、腎炎、肝炎、糖尿病等)、美容・皮膚病
(しみ、そばかす、肌荒れ、冷え症、便秘、しわ、アト
ピー性皮膚炎等)等の治療、改良等に優れた効果を発揮
するものと考えられる。また、本発明の血圧抑制剤及び
便秘改良剤は、各々血圧の抑制効果及び便通を良くする
効果に優れる。更に、水溶性の健康・美容増進剤等の場
合は、吸収効果に優れるとともに、水溶性飲料、食品等
としてその適用分野が広くなる。
EFFECTS OF THE INVENTION Since the health and beauty promoting agent is excellent in SOD action, it is also excellent in the effects resulting from the SOD action (for example, blood pressure suppressing effect). Therefore, by using this health and beauty enhancer, various diseases caused by active oxygen, for example,
Diseases caused by blood flow disorders (myocardial infarction, stroke, high blood pressure, menstrual cramps, stiff shoulders, neuralgia, back pain, hangover, etc.), adult diseases / internal diseases (cancer, nephritis, hepatitis, diabetes, etc.), beauty / skin diseases (stains, freckles) , Rough skin, chills, constipation, wrinkles, atopic dermatitis, etc.), etc., and is considered to exhibit excellent effects. Further, the blood pressure inhibitor and the constipation improving agent of the present invention are excellent in the effect of suppressing blood pressure and the effect of improving bowel movements, respectively. Further, in the case of a water-soluble health / beauty enhancer or the like, it has an excellent absorption effect, and its application field is broadened as a water-soluble beverage or food.

【0036】また、特に、本発明に主成分として用いら
れる発酵液は、完全な天然原料による自然発酵物のた
め、有害な菌及び重金属は認められず、安全であるとと
もに本来、健康・美容増進として有用な米糠及び大豆製
品を原料としているので、且つ有用な窒素化合物(アミ
ノ酸等)、灰分、リン化合物等が含まれているので、大
変バランスの良い健康・美容増進剤等である。更に、緑
茶抽出エキスも天然物を利用したもののため、これを含
む健康・美容増進剤等の安全性も優れる。
Further, in particular, the fermented liquor used as the main component in the present invention is a natural fermented product of a completely natural raw material, so that harmful bacteria and heavy metals are not recognized, and it is safe and originally promotes health and beauty. It is a very well-balanced health and beauty enhancer since it is made from rice bran and soybean products which are useful as a raw material and contains useful nitrogen compounds (amino acids etc.), ash and phosphorus compounds. Furthermore, since the green tea extract is also a natural product, the safety of health and beauty enhancer containing it is excellent.

【図面の簡単な説明】[Brief description of drawings]

【図1】実施例におけるSHRの血圧上昇期における血
圧の変動を示すグラフである。
FIG. 1 is a graph showing changes in blood pressure during SHR blood pressure elevation in an example.

【図2】実施例におけるSHRの高血圧完成期における
血圧の変動を示すグラフである。
FIG. 2 is a graph showing fluctuations in blood pressure in the SHR hypertension completion period in Examples.

───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.6 識別記号 庁内整理番号 FI 技術表示箇所 // A23F 3/16 ─────────────────────────────────────────────────── ─── Continuation of the front page (51) Int.Cl. 6 Identification code Internal reference number FI technical display location // A23F 3/16

Claims (15)

【特許請求の範囲】[Claims] 【請求項1】 米糠類、大豆類及び水を含む培地に枯草
菌を接種し、培養させ、濾過して製造した発酵液又は該
発酵液の蒸発残分に、緑茶抽出エキス又は該緑茶抽出エ
キスの蒸発残分を含有させてなることを特徴とするSO
D作用を有する健康・美容増進剤。
1. A fermented liquor produced by inoculating Bacillus subtilis into a medium containing rice bran, soybeans, and water, culturing and filtering, or the evaporation residue of the fermented liquor, to which the green tea extract or the green tea extract is added. SO containing the evaporation residue of
Health and beauty enhancer with D action.
【請求項2】 上記緑茶抽出エキスは、その蒸発残分換
算にて、上記発酵液の蒸発残分100重量部に対して1
〜50重量部配合される請求項1記載のSOD作用を有
する健康・美容増進剤。
2. The green tea extract is 1 in terms of the evaporation residue, based on 100 parts by weight of the evaporation residue of the fermentation liquor.
The health / beauty enhancer having an SOD action according to claim 1, which is mixed in an amount of 50 parts by weight.
【請求項3】 上記緑茶抽出エキスはメタノール及びエ
タノールの少なくとも一方から抽出された水溶性のもの
である請求項1又は2記載の健康・美容増進剤。
3. The health / beauty enhancer according to claim 1, wherein the green tea extract is a water-soluble extract extracted from at least one of methanol and ethanol.
【請求項4】 米糠類、大豆類及び水を含む培地に枯草
菌を接種し、培養させ、濾過して製造した発酵液又は該
発酵液の蒸発残分に、フラボノイドを含有させてなるこ
とを特徴とするSOD作用を有する健康・美容増進剤。
4. A fermentation liquor produced by inoculating a culture medium containing rice bran, soybeans and water with Bacillus subtilis, culturing and filtering the mixture, or an evaporation residue of the fermentation liquor containing flavonoids. A health and beauty enhancer with a characteristic SOD action.
【請求項5】 フィチン酸及びその塩の少なくとも一方
と、緑茶抽出エキス又は該緑茶抽出エキスの蒸発残分と
を含有させてなることを特徴とするSOD作用を有する
健康・美容増進剤。
5. A health / beauty enhancer having an SOD action, comprising at least one of phytic acid and a salt thereof, and a green tea extract or an evaporation residue of the green tea extract.
【請求項6】 米糠類、大豆類及び水を含む培地に枯草
菌を接種し、培養させ、濾過して製造した発酵液又は該
発酵液の蒸発残分に、緑茶抽出エキス又は該緑茶抽出エ
キスの蒸発残分を含有させてなることを特徴とする血圧
抑制剤。
6. A green tea extract or said green tea extract in a fermentation liquor produced by inoculating a culture medium containing rice bran, soybeans and water with Bacillus subtilis, culturing and filtering, or an evaporation residue of the fermentation liquor. An antihypertensive agent comprising the evaporation residue of
【請求項7】 上記緑茶抽出エキスは、その蒸発残分換
算にて、上記発酵液の蒸発残分100重量部に対して1
〜50重量部配合される請求項6記載のSOD作用を有
する血圧抑制剤。
7. The green tea extract extract is 1 in 100 parts by weight of the evaporation residue of the fermentation broth, calculated as the evaporation residue.
The blood pressure suppressor having the SOD effect according to claim 6, which is mixed in an amount of -50 parts by weight.
【請求項8】 上記緑茶抽出エキスはメタノール及びエ
タノールの少なくとも一方から抽出された水溶性のもの
である請求項6又は7記載の血圧抑制剤。
8. The blood pressure suppressant according to claim 6, wherein the green tea extract is a water-soluble extract extracted from at least one of methanol and ethanol.
【請求項9】 米糠類、大豆類及び水を含む培地に枯草
菌を接種し、培養させ、濾過して製造した発酵液又は該
発酵液の蒸発残分に、フラボノイドを含有させてなるこ
とを特徴とする血圧抑制剤。
9. A flavonoid is contained in a fermentation liquor produced by inoculating Bacillus subtilis into a medium containing rice bran, soybeans and water, culturing and filtering, or the evaporation residue of the fermentation liquor. Characteristic blood pressure suppressant.
【請求項10】 フィチン酸及びその塩の少なくとも一
方と、緑茶抽出エキス又は該緑茶抽出エキスの蒸発残分
とを含有させてなることを特徴とする血圧抑制剤。
10. An antihypertensive agent comprising at least one of phytic acid and a salt thereof, and a green tea extract or an evaporation residue of the green tea extract.
【請求項11】 米糠類、大豆類及び水を含む培地に枯
草菌を接種し、培養させ、濾過して製造した発酵液又は
該発酵液の蒸発残分に、緑茶抽出エキス又は該緑茶抽出
エキスの蒸発残分を含有させてなることを特徴とする便
秘改良剤。
11. A fermented liquor produced by inoculating Bacillus subtilis into a medium containing rice bran, soybeans and water, culturing and filtering the mixture, or an evaporative residue of the fermented liquor, a green tea extract or the green tea extract. A constipation-improving agent characterized by containing the evaporation residue of.
【請求項12】 上記緑茶抽出エキスは、その蒸発残分
換算にて、上記発酵液の蒸発残分100重量部に対して
1〜50重量部配合される請求項11記載の便秘改良
剤。
12. The constipation-improving agent according to claim 11, wherein the green tea extract extract is added in an amount of 1 to 50 parts by weight based on 100 parts by weight of the evaporation residue of the fermentation broth in terms of the evaporation residue.
【請求項13】 上記緑茶抽出エキスはメタノール及び
エタノールの少なくとも一方から抽出された水溶性のも
のである請求項11又は12記載の便秘改良剤。
13. The constipation improving agent according to claim 11, wherein the green tea extract is a water-soluble extract extracted from at least one of methanol and ethanol.
【請求項14】 米糠類、大豆類及び水を含む培地に枯
草菌を接種し、培養させ、濾過して製造した発酵液又は
該発酵液の蒸発残分に、フラボノイドを含有させてなる
ことを特徴とする便秘改良剤。
14. A fermentation liquor produced by inoculating Bacillus subtilis into a medium containing rice bran, soybeans and water, culturing and filtering the mixture, or an evaporation residue of the fermentation liquor containing flavonoids. Characteristic constipation improver.
【請求項15】 フィチン酸及びその塩の少なくとも一
方と、緑茶抽出エキス又は該緑茶抽出エキスの蒸発残分
とを含有させてなることを特徴とする便秘改良剤。
15. A constipation-improving agent comprising at least one of phytic acid and a salt thereof and a green tea extract or an evaporation residue of the green tea extract.
JP6242072A 1994-09-09 1994-09-09 Health and beauty-promoting agent having sod action, blood pressure-suppressing agent and constipation-improving agent Pending JPH0881381A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP6242072A JPH0881381A (en) 1994-09-09 1994-09-09 Health and beauty-promoting agent having sod action, blood pressure-suppressing agent and constipation-improving agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6242072A JPH0881381A (en) 1994-09-09 1994-09-09 Health and beauty-promoting agent having sod action, blood pressure-suppressing agent and constipation-improving agent

Publications (1)

Publication Number Publication Date
JPH0881381A true JPH0881381A (en) 1996-03-26

Family

ID=17083870

Family Applications (1)

Application Number Title Priority Date Filing Date
JP6242072A Pending JPH0881381A (en) 1994-09-09 1994-09-09 Health and beauty-promoting agent having sod action, blood pressure-suppressing agent and constipation-improving agent

Country Status (1)

Country Link
JP (1) JPH0881381A (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09309833A (en) * 1996-05-22 1997-12-02 Toyo Hakko:Kk Active oxygen-suppressing composition and its production and hypotensive medicine
WO2003013565A1 (en) * 2001-08-08 2003-02-20 Toyo Hakko Co., Ltd. Functional materials, sod agonists, hypotensives and thrombolytics, process for producing the same and microbial strains to be used therein
JP2005325034A (en) * 2004-05-12 2005-11-24 Okuno Chem Ind Co Ltd Singlet oxygen eliminator
JP2006191924A (en) * 2004-12-15 2006-07-27 Kao Corp Method for producing refined green tea extract
JPWO2010050179A1 (en) * 2008-10-27 2012-03-29 Sbiアラプロモ株式会社 A preventive / ameliorating agent for adult diseases comprising 5-aminolevulinic acid or a derivative thereof, or a salt thereof as an active ingredient
JP2015086207A (en) * 2013-11-01 2015-05-07 株式会社東洋発酵 Oral composition for beauty and health
CN107467234A (en) * 2017-09-26 2017-12-15 青田峰之润茶业有限公司 A kind of processing technology using strain fermentation black tea

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09309833A (en) * 1996-05-22 1997-12-02 Toyo Hakko:Kk Active oxygen-suppressing composition and its production and hypotensive medicine
WO2003013565A1 (en) * 2001-08-08 2003-02-20 Toyo Hakko Co., Ltd. Functional materials, sod agonists, hypotensives and thrombolytics, process for producing the same and microbial strains to be used therein
JP2005325034A (en) * 2004-05-12 2005-11-24 Okuno Chem Ind Co Ltd Singlet oxygen eliminator
JP2006191924A (en) * 2004-12-15 2006-07-27 Kao Corp Method for producing refined green tea extract
JP4528702B2 (en) * 2004-12-15 2010-08-18 花王株式会社 Method for producing purified green tea extract
JPWO2010050179A1 (en) * 2008-10-27 2012-03-29 Sbiアラプロモ株式会社 A preventive / ameliorating agent for adult diseases comprising 5-aminolevulinic acid or a derivative thereof, or a salt thereof as an active ingredient
JP5665544B2 (en) * 2008-10-27 2015-02-04 Sbiファーマ株式会社 A preventive / ameliorating agent for adult diseases comprising 5-aminolevulinic acid or a derivative thereof, or a salt thereof as an active ingredient
US9095165B2 (en) 2008-10-27 2015-08-04 Sbi Pharmaceuticals Co., Ltd. Prophylactic/ameliorating agent for adult diseases comprising 5-aminolevulinic acid, derivative of 5-aminolevulinic acid, or salt of 5-aminolevulinic acid or the derivative of 5-aminolevulinic acid as active ingredient
US9730904B2 (en) 2008-10-27 2017-08-15 Sbi Pharmaceuticals Co., Ltd. Prophylactic/ameliorating agent for adult diseases comprising 5-aminolevulinic acid, derivative of 5-aminolevulinic acid, or salt of 5-aminolevulinic acid or the derivative of 5-aminolevulinic acid as active ingredient
JP2015086207A (en) * 2013-11-01 2015-05-07 株式会社東洋発酵 Oral composition for beauty and health
CN107467234A (en) * 2017-09-26 2017-12-15 青田峰之润茶业有限公司 A kind of processing technology using strain fermentation black tea

Similar Documents

Publication Publication Date Title
EP3351258A1 (en) Equal-containing fermentation product of soybean embryonic axis, and method for production thereof
JP4669920B2 (en) Functional material that suppresses blood glucose rise and blood pressure rise
CN104982928B (en) A kind of japanese yew fruit health care ferment and preparation method thereof
JPH06284872A (en) Health and beauty promoter, blood pressure suppressor and constipation improver having sod action
CN104379155A (en) Composition comprising extract of mixture of undaria pinnatifida sporophylls and ascidian shells for treating atopic dermatitis
CN103327995B (en) For reducing the composition that comprises fermented tea extract of lipid level
US20020018818A1 (en) Sugar decomposition inhibitor, digestive enzyme activity inhibitor, insulin secretion controller, and healthy food and beverage
US5776756A (en) Fermentation compositions having superoxide dismutating activity and an antihypertensive agent for treatment of constipation each having the superoxide dismutating activity
JP2006347952A (en) Anthraquinone derivative exerting lipase activating effect and antiobesity drug, food preparation and cosmetic comprising the same
JPH0881381A (en) Health and beauty-promoting agent having sod action, blood pressure-suppressing agent and constipation-improving agent
KR101371143B1 (en) Composition comprising chlorella for improving liver function or relieving hangover
KR20040106367A (en) Difructose anhydride-containing composition and use thereof
US20130017181A1 (en) Lipid-metabolism-ameliorating agent
KR100687546B1 (en) Composition having SOD activity, and blood-pressure controlling agent containing the same
JPH09309833A (en) Active oxygen-suppressing composition and its production and hypotensive medicine
CN103182004B (en) Containing tealeaves, camellia and tea seed extract, for preventing or improving the composition of metabolic syndrome
TW201039839A (en) Composition for regulating antonomic nervous activity and method for regulating autonomic nervous
JP2004024004A (en) Fermentation composition and anti-oxidizing composition containing the same
KR101720681B1 (en) Composition for promoting sleep including hop extract
KR0166130B1 (en) Fermentation composition with sod function
JPH06315359A (en) Fermentation composition having sod action
KR20190014220A (en) Composition of mixed ferment extraction liquid for hangover elimination and hangover eliminator containing composition as effective ingredient thereof
US20060024327A1 (en) Composition for controlling blood sugar
TWI719781B (en) Use of herb ferment for preparing a composition for preventing obesity
JP2005022988A (en) Composition for promoting sugar transport of muscle cell comprising mugwort as active ingredient